What is the role of genetic testing in diagnosis of haemochromatosis?

Annals of Clinical Biochemistry

Volumn 38, Issue 1, 2001, Pages 3-19

  Worwood, M ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN; IRON BINDING PROTEIN; TRANSFERRIN;

ANTIGEN ANTIBODY COMPLEX; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE TRANSMISSION; EARLY DIAGNOSIS; GENE MUTATION; GENETIC ANALYSIS; GENETIC SCREENING; HEMOCHROMATOSIS; HUMAN; IRON ABSORPTION; IRON BLOOD LEVEL; LIFE EXPECTANCY; PREVALENCE; PRIORITY JOURNAL; REVIEW; SKIN PIGMENTATION; TRANSFERRIN BLOOD LEVEL;

AFRICA; EUROPE; FEMALE; GENETIC SCREENING; GENETIC TECHNIQUES; GENOTYPE; HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; MALE; MEMBRANE PROTEINS; MUTATION; PENETRANCE; PHENOTYPE; POLYMERASE CHAIN REACTION;

EID: 0035161979     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1258/0004563011900236     Document Type: Review

References (116)

1. Long-term survival in patients with hereditary hemochromatosis
2. Hereditary hemochromatosis: Etiologic, pathologic, and clinical aspects
3. Evidence of genetic transmission in African iron overload
4. Neonatal hemochromatosis
5. Juvenile hemochromatosis: Locus maps to chromosome 1q
6. Idiopathic haemochromatosis: An autosomal recessive disease
7. An immunoradiometric assay for ferritin in the serum of normal subjects and patients with iron deficiency and iron overload
8. Hémochromatose idiopathique. Maladie associée à l'antigène tissulaire HL-A3?
9. Screening for hemochromatosis
10. Serum ferritin
11. Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis
12. Evaluation of transfusional iron overload before and during iron chelation by magnetic resonance imaging of the liver and determination of serum ferritin in adult non-thalassaemic patients
13. Noninvasive methods for the early detection of hereditary hemochromatosis
14. Serum ferritin concentration and iron stores in normal subjects
15. Genetics of haemochromatosis
16. A survey of 2,851 patients with hemochromatosis: Symptoms and response to treatment
17. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis
18. Putting a hold on 'HLA-H'
19. Iron overload in beta2-microglobulin-deficient mice
20. Beta(2) knockout mice develop parenchymal iron overload: A putative role for class I genes of the major histocompatibility complex in iron metabolism
21. The hemochromatosis founder mutation in HLA-H disrupts beta(2)-microglobulin interaction and cell surface expression
22. The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding
23. Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor
24. Crystal structure of the hereditary haemochromatosis protein HFE complexed with transferrin receptor
25. HFE gene knockout produces mouse model of hereditary hemochromatosis
26. HLA-H mutations in the Ashkenazi Jewish population
27. Haemochromatosis and HLA-H
28. Global prevalence of putative haemochromatosis mutations
29. Simple and rapid detection of the newly described mutations in the HLA-H gene
30. Simple multiplex PCR for the simultaneous detection of the C282Y and H63D hemochromatosis (HFE) gene mutations
31. Rapid genetic screening for haemochromatosis using heteroduplex technology
32. A single tube heteroduplex PCR for the common HFE genotypes
33. Rapid detection of genetic mutations associated with haemochromatosis
34. A rapid method of haplotyping HFE mutations and linkage disequilibrium in a Caucasoid population
35. A PCR-SSP method for detecting the Cys282Tyr mutation in the HFE gene associated with hereditary haemochromatosis
36. Determination of gene frequencies for two common haemochromatosis mutations in the Danish population by a novel polymerase chain reaction with sequence-specific primers
37. A rapid automated SSCP multiplex capillary electrophoresis protocol that detects the two common mutations implicated in hereditary hemochromatosis (HH)
38. Rapid genetic screening for hemochromatosis using automated SSCP-based capillary electrophoresis (SSCP-CE)
39. Rapid genotyping of hemochromatosis gene mutations on the lightcycler with fluorescent hybridization probes
40. Dietary iron overload as a risk factor for hepatocellular carcinoma in Black Africans
41. Rapid detection of the factor V Leiden (1691GA) and haemochromatosis (845G > A) mutation by fluorescence resonance energy transfer (FRET) and real time PCR
42. A rapid non-invasive method for the detection of the haemochromatosis C282Y mutation
43. Prevalence of HFE (hemochromatosis gene) mutations in unselected male patients with type 2 diabetes
44. High incidence of the Cys 282 Tyr mutation in the HFE gene in the Irish population - Implications for haemochromatosis
45. Haemochromatosis - Prevalence and penetrance in blood donors resident in Wales
46. Mutations in the MHC class 1-like candidate gene for hemochromatosis in French patients
47. A candidate gene for hemochromatosis: Frequency of the C282Y and H63D mutations
48. Allele frequencies of hereditary hemochromatosis gene mutations in a local population of west Brittany
49. Phenotype-genotype correlation in haemochromatosis subjects
50. Predominance of the HLA-H Cys282Tyr mutation in Austrian patients with genetic haemochromatosis
51. HFE codon 63/282 (H63D/C282Y) dimorphism in German patients with genetic hemochromatosis
52. High frequency of the haemochromatosis C282Y mutation in Hungary could argue against a Celtic origin of the mutation
53. The frequency of the haemochromatosis C282Y mutation in the ethnic Hungarian and Romany populations of Eastern Hungary
54. Ethnic differences in the HFE codon 282 (Cys/Tyr) polymorphism
55. Prevalence of the Cys282Tyr and His63Asp HFE gene mutations in Spanish patients with hereditary hemochromatosis and in controls
56. Absence of the hemochromatosis gene Cys282Tyr mutation in three ethnic groups from Algeria (Mzab), Ethiopia, and Senegal
57. HLA-H and associated proteins in patients with hemochromatosis
58. Transferrin receptor mutation analysis in hereditary hemochromatosis patients
59. Atypical haemochromatosis: Phenotypic spectrum and beta(2)-microglobulin gene analysis
60. A single nucleotide deletion in the putative haemochromatosis gene in a patient who is negative for the C282Y and H63D mutations
61. A novel mutation of HFE explains the classical phenotype of genetic hemochromatosis in a C282Y heterozygote
62. HFE mutations in 711 hemochromatosis probands: Evidence for S65C implication in mild form of hemochromatosis
63. Two novel missense mutations of the HFE gene (I105T and G93R) and identification of the S65C mutation in Alabama hemochromatosis probands
64. Polymorphism in intron 4 of HFE may cause overestimation of C282Y homozygote prevalence in haemochromatosis
65. An HFE intronic variant promotes misdiagnosis of hereditary hemochromatosis
66. Polymorphism in intron 4 of HFE does not compromise haemochromatosis mutation results
67. Hereditary haemochromatosis mutations (HFE) in patients with type II diabetes mellitus
68. C282Y mutation in HFE (haemochromatosis) gene and type 2 diabetes
69. The prevalence of hereditary haemochromatosis in a diabetic population
70. Prevalence of hereditary haemochromatosis in premature atherosclerotic vascular disease
71. Heterozygotes for HFE mutations have no increased risk of advanced alcoholic liver disease
72. Screening for genetic haemochromatosis in blood samples with raised alanine aminotransferase
73. Incidence of liver disease in people with HFE mutations
74. Haemochromatosis gene C282Y homozygotes in an elderly male population
75. Secondary iron overload and the haemochromatosis allele
76. Mutations in the hemochromatosis gene, porphyria cutanea tarda, and iron overload
77. Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda
78. High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda
79. Haemochromatosis Cys282Tyr mutation in pyridoxine-responsive sideroblastic anaemia
80. Four new mutations in the erythroid-specific 5-aminolevulinate synthase (ALAS2) gene causing X-linked sideroblastic anemia: Increased pyridoxine responsiveness after removal of iron overload by phlebotomy and coinheritance of hereditary hemochromatosis
81. Genetics of hemochromatosis
82. Expression of hemochromatosis in homozygous subjects. Implications for early diagnosis and prevention
83. Prevalence of abnormal iron studies in heterozygotes for hereditary hemochromatosis: An analysis of 255 heterozygotes
84. Heterozygosity for the C282Y mutation in the hemochromatosis gene is associated with increased serum iron, transferrin saturation, and hemoglobin in young women: A protective role against iron deficiency?
85. The significance of haemochromatosis gene mutations in the general population: Implications for screening
86. Heterozygosity for a hereditary hemochromatosis gene is associated with cardiovascular death in women
87. Increased risk of acute myocardial infarction in carriers of the hemochromatosis gene Cys282Tyr mutation - A prospective cohort study in men in eastern Finland
88. Population screening for hemochromatosis: Expectations based on a study of relatives of symptomatic patients
89. The relationship between iron overload, clinical symptoms, and age in 410 patients with genetic hemochromatosis
90. A population-based study of the clinical expression of the hemochromatosis gene
91. A comparison of unbound iron-binding capacity, transferrin saturation and C282y genotyping in 5211 voluntary blood donors
92. Haemochromatosis - HFE mutations and iron status in 10,000 blood donors from South Wales
93. A simple genetic test identifies 90% of UK patients with haemochromatosis
94. Mutation analysis in hereditary hemochromatosis
95. Mutation analysis of the HLA-H gene in Italian hemochromatosis patients
96. Genetic and clinical description of hemochromatosis probands and heterozygotes: Evidence that multiple genes linked to the major histocompatibility complex are responsible for hemochromatosis
97. Compound heterozygotes for hemochromatosis gene mutations: May they help to understand the pathophysiology of the disease?
98. Hemochromatosis screening in asymptomatic ambulatory men 30 years of age and older
99. Prevalence of hemochromatosis among 11,065 presumably healthy blood donors
100. Twenty-four hour variation of transferrin saturation in treated and untreated haemochromatosis homozygotes
101. Prevalence of elevated serum transferrin saturation in adults in the United States
102. When is a serum iron really a serum iron? A follow-up study on the status of iron measurements in serum
103. Revised recommendations for the measurement of serum iron in human blood
104. The measurement of total and unsaturated iron binding capacity in serum
105. Transferrin saturation and screening of genetic hemochromatosis
106. Three commercial automated ferritin assays
107. Hereditary haemochromatosis and blood donation
108. Whose rights are they anyway?
109. Cost-effectiveness analysis for evaluation of screening programs: Hereditary hemochromatosis
110. Cost-effectiveness of screening for hereditary hemochromatosis
111. Screening blood donors for hereditary hemochromatosis: Decision analysis model based on a 30-year database
112. Analysis of the cost of population screening for haemochromatosis using biochemical and genetic markers